News and Trends 22 Aug 2022 EpiVario looks to biotech for PTSD treatment …confirmed that a small molecule inhibitor against ACSS2 can block the epigenetic process required for the consolidation of stress and fear memories. In the study, the researchers identified the metabolic… August 22, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 22 Aug 2025 The Sanofi pipeline in 2025: Is the play-to-win strategy working? …asset Ayvakit, the acquisition adds early programs in KIT-driven diseases that aim to broaden treatment to less-advanced or adjacent patient groups. Strategically, that complements Sanofi’s existing immunology footprint, but execution… August 22, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jul 2017 British Researchers “Calm Down” Macrophages to treat Inflammation …to humans in order to restore normal metabolism in many inflammatory diseases. However, given the early stage of the study, more information is needed before that. Behmoaras wants to study… July 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jan 2020 T-Cell Discovery Could Herald Universal Cancer Immunotherapy …T-cells (red) attacking a cancer cell (white). A key aspect of MR1 is that the protein reveals the metabolic ‘signature’ of the cell that is being scanned by the immune… January 21, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2022 EMPA-KIDNEY trial meets primary endpoint in trial for drug to treat chronic kidney disease …spectrum of cardiovascular, kidney or metabolic conditions. The trial assessed both kidney and cardiovascular outcomes in people across the spectrum of CKD severity. “The Boehringer Ingelheim and Lilly Alliance is incredibly proud… November 4, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 10 Mar 2022 Emerging Startups Take Aim at Lysosomal Storage Disorders …to treat these conditions by activating protective genes. Lysosomal storage disorders are inherited conditions caused by mutations in metabolic enzymes found inside our cells, leading to the buildup of toxic… March 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 6 Feb 2020 Why a Big Pharma Background Can Give Biotech Leaders an Edge …disease, but will die of cardiovascular diseases. Most patients have metabolic syndrome and are at high risk for cardiovascular disease. Besides that, you also see more activity around triglyceride-lowering treatments… February 6, 2020 - 11 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 13 Nov 2025 iGEM Jamboree: leap into the synthetic biology future …duckweed engineering fivefold; the CULTIVATOR, a self-driving growth unit that monitors, harvests, and optimizes biomass; and the PREDICTOR, an AI model that learns the metabolic rhythms of the plant to… November 13, 2025 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 12 Jun 2023 Six advancements in Alzheimer’s research over the past year …not interfere with other cyclin-dependent kinases – enzymes that regulate the cell cycle. As P25 has been linked to multiple neurodegenerative diseases, this could be a therapeutic breakthrough for conditions… June 12, 2023 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 11 Aug 2022 First patient enrolled on Panbela’s trial for treatment of pancreatic cancer …with programs ranging from pre-clinical to registration studies. SBP-101 is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition by exploiting an observed high affinity of the compound for… August 11, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 4 Apr 2017 Top Young Researchers Making Names for Themselves in Industry …with an industrial yeast strain through metabolic engineering. Anastasia Krivoruchko After finishing her PhD at Carleton University, Canada, Anastasia Krivoruchko went on to do a postdoc at Chalmers University of… April 4, 2017 - 4 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 Oct 2023 Five impactful biotech companies to know in New York …targeting diseases such as depression, Alzheimer’s disease agitation, migraine, narcolepsy, and fibromyalgia. In Just last year, the U.S. Food and Drug Administration (FDA) approved Axsome’s drug Auvelity (dextromethorphan HBr -bupropion… October 3, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email